© 2020 MJH Life Sciences and Practical Cardiology. All rights reserved.
Heart Disease and Diabetes
Increased Risk of Ischemic Heart Disease Associated With Pre-Term Deliveries
June 29, 2020
New research from an analysis of the Swedish Medical Birth Registry suggests women experience preterm delivery were at an increased risk of developing ischemic heart disease later in life.
Diabetes Trial Shows Prevention Benefits Two Decades Later
June 16, 2020
New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes (T2D) in at risk populations.
Type 1 Diabetes Triggered First Two Years of Life, Research Says
June 15, 2020
New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The research, presented in a symposium at the American Diabetes Association meeting.shows that the destruction of the beta cells begins in the first two years of life.
Late Night Meals Bad for Blood Sugar Control and Weight Loss
June 12, 2020
A study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism has found that eating a late may be a contributing factor to weight gain and hyperglycemia -- factors that may also exaccerbate heart disease.
Glucose Management of COVID-19 Patients in the ICU Gets New Provider Guidelines
June 10, 2020
According to the report, more than 20 percent of COVID patients in the ICU are patients with diabetes, presenting challenges for the clinicians managing their care. Diabetic patients with COVID-19 in the ICU need both complex medical management of their COVID disease, along with blood sugar control to minimize complications and mortality risk- and that can require multiple patient interactions that put the provider at risk.
FDA Expands Use of Ticagrelor to Patients Without History of MI or Stroke
June 02, 2020
The oral antiplatelet drug Ticagrelor (Brilinta, Astra Zeneca), was approved this week by the US Food and Drug Administration (FDA) for use in patients with coronary artery disease (CAD) who are at high risk for a first heart attack or stroke.
SGLT2 Inhibitors May Reduce Kidney Problems in Diabetics
April 29, 2020
The use of a commonly prescribed diabetes drug known as a sodium glucose cotransporter 2 (SGLT2) inhibitor to treat type 2 diabetes may help to lower the risk of serious kidney problems.
ACEi and ARBs Do Not Increase Risk of COVID-19 Infection Says European Society of Cardiology
March 18, 2020
Physicians and patients should continue treatment with their usual anti-hypertensive or diabetes management therapy, says the European Society of Cardiology (ESC). There is no evidence that ACEi or ARBs, drugs which upregulate Angiotensin Converting Enzyme (ACE), increase the risk of contracting COVID-19, the society said in a statement published March 13.
Heart Disease and Diabetes Increase Coronavirus Risk
March 11, 2020
Patients with cardiovascular disease, respiratory disease, cancer and diabetes are at increased risk for contracting COVID-19 and have a worse prognosis, said the American College of Cardiology in a clinical bulletin released March 6.
Vascepa for CVD Prevention Among Most Noteworthy Achievements of the Decade
January 06, 2020
The U.S. Food and Drug Administration has approved an omega-3 fatty acid treatment as an add-on treatment to statin therapy to reduce the risk of cardiovascular disease in adults with elevated triglyceride levels.